Atovaquone Suspension
Product Images NDC 0121-1016

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 0121-1016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pai Holdings, Llc Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C:\users\admin\desktop\new Folder (3)\image2.jpg (Atovaquone 1)

Chemical structure of atovaquone, showing its molecular framework including aromatic rings and functional groups.*

FDA Label Image

A1016050923 (Atovaquone 2)

Label for Atovaquone Oral Suspension USP 750 mg/5 mL by PAI Pharma. The label indicates a 5 mL delivery per dose, includes a barcode, and states the product is Rx only and not child-resistant. The label advises to shake gently before use and refers users to the insert for more information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.